Jose Arcadio Rodriguez-Martinez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jose Arcadio Rodriguez-Martinez has a total of 153 co-authors. Here are the top co-authors by number of shared publications:
- Alejandro Rivera-Madera
University of California Berkeley
7 shared publications - Edwin G. Peña-Martínez
University of Puerto Rico-Río Piedras
7 shared publications Diego A. Pomales-Matos
Department of Biology, University of Puerto Rico-Río Piedras Campus, San Juan, PR 00931
6 shared publicationsAdriana C. Barreiro-Rosario
Department of Biology, University of Puerto Rico-Rio Piedras, San Juan, PR 00931, USA
5 shared publications- Aseem Z. Ansari
Department of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706, USA
5 shared publications Devesh Bhimsaria
Indian Institute of Technology Roorkee
5 shared publications
Latest Publications
- Open Access
- 7 January 2026
- Published by Springer Nature in Research Square
Global Evaluation of Congenital Heart Disease-Associated Non-Coding Variants
Genome-wide association studies (GWAS) have mapped thousands of congenital heart disease (CHD)-associated variants within non-coding regions of the genome. Non-coding variants can alter regulatory mechanisms, such as transcription factor (TF) binding control of gene expression, potentially contributing human diseases. However, with the increasing number of disease-associated variants, comprehensive functional validation remains a significant challenge. In this work, we developed a novel method called SNP Bind-n-Seq to evaluate >3,000 CHD-risk variants for allelic binding for the cardiac TFs NKX2-5, GATA4, and TBX5 in a high-throughput manner. These binding affinity data sets were coupled with a massively parallel reporter assay (MPRA) to screen CHD-risk variant genotype-dependent regulatory activity. We identified 170 variants that exhibit allelic TF binding and 187 that modulate gene expression. Combining both approaches revealed three high-confidence variants with genotype-dependent TF binding, genotype-dependent transcriptional activity, and eQTL behavior in cardiac cells. Collectively, this study provides the first combined high-throughput biochemical and functional genomic evaluation of thousands of CHD-risk variants.
- 7 January 2026
- Published by Springer Nature in Research Square
Open AccessGlobal Evaluation of Congenital Heart Disease-Associated Non-Coding Variants
Genome-wide association studies (GWAS) have mapped thousands of congenital heart disease (CHD)-associated variants within non-coding regions of the genome. Non-coding variants can alter regulatory mechanisms, such as transcription factor (TF) binding control of gene expression, potentially contributing human diseases. However, with the increasing number of disease-associated variants, comprehensive functional validation remains a significant challenge. In this work, we developed a novel method called SNP Bind-n-Seq to evaluate >3,000 CHD-risk variants for allelic binding for the cardiac TFs NKX2-5, GATA4, and TBX5 in a high-throughput manner. These binding affinity data sets were coupled with a massively parallel reporter assay (MPRA) to screen CHD-risk variant genotype-dependent regulatory activity. We identified 170 variants that exhibit allelic TF binding and 187 that modulate gene expression. Combining both approaches revealed three high-confidence variants with genotype-dependent TF binding, genotype-dependent transcriptional activity, and eQTL behavior in cardiac cells. Collectively, this study provides the first combined high-throughput biochemical and functional genomic evaluation of thousands of CHD-risk variants.
- Open Access
Global Evaluation of Congenital Heart Disease-Associated Non-Coding Variants
(Summary): Genome-wide association studies (GWAS) have mapped thousands of congenital heart disease (CHD)-associated variants within non-coding regions of the genome. Non-coding variants can alter regulatory mechanisms, such as transcription factor (TF) binding control of gene expression, potentially contributing human diseases. However, with the increasing number of disease-associated variants, comprehensive functional validation remains a significant challenge. In this work, we developed a novel method called SNP Bind-n-Seq to evaluate >3,000 CHD-risk variants for allelic binding for the cardiac TFs NKX2-5, GATA4, and TBX5 in a high-throughput manner. These binding affinity data sets were coupled with a massively parallel reporter assay (MPRA) to screen CHD-risk variant genotype-dependent regulatory activity. We identified 170 variants that exhibit allelic TF binding and 187 that modulate gene expression. Combining both approaches revealed three high-confidence variants with genotype-dependent TF binding, genotype-dependent transcriptional activity, and eQTL behavior in cardiac cells. Collectively, this study provides the first combined high-throughput biochemical and functional genomic evaluation of thousands of CHD-risk variants. Highlights: Allelic binding affinity measurements of ∼9,600 variants for NKX2-5, GATA4, and TBX5 EvaluaFon of >3,000 CHD-risk variants for genotype-dependent regulatory acFvity InteracFon networks idenFfy funcFonal variants and genes involving cardiac eQTLs Graphical
Open AccessGlobal Evaluation of Congenital Heart Disease-Associated Non-Coding Variants
(Summary): Genome-wide association studies (GWAS) have mapped thousands of congenital heart disease (CHD)-associated variants within non-coding regions of the genome. Non-coding variants can alter regulatory mechanisms, such as transcription factor (TF) binding control of gene expression, potentially contributing human diseases. However, with the increasing number of disease-associated variants, comprehensive functional validation remains a significant challenge. In this work, we developed a novel method called SNP Bind-n-Seq to evaluate >3,000 CHD-risk variants for allelic binding for the cardiac TFs NKX2-5, GATA4, and TBX5 in a high-throughput manner. These binding affinity data sets were coupled with a massively parallel reporter assay (MPRA) to screen CHD-risk variant genotype-dependent regulatory activity. We identified 170 variants that exhibit allelic TF binding and 187 that modulate gene expression. Combining both approaches revealed three high-confidence variants with genotype-dependent TF binding, genotype-dependent transcriptional activity, and eQTL behavior in cardiac cells. Collectively, this study provides the first combined high-throughput biochemical and functional genomic evaluation of thousands of CHD-risk variants. Highlights: Allelic binding affinity measurements of ∼9,600 variants for NKX2-5, GATA4, and TBX5 EvaluaFon of >3,000 CHD-risk variants for genotype-dependent regulatory acFvity InteracFon networks idenFfy funcFonal variants and genes involving cardiac eQTLs Graphical
- Open Access
- 2 August 2025
- Published by Oxford University Press (OUP) in G3: Genes, Genomes, Genetics
- Vol. 15 (10)
Congenital heart disease missense mutations in the TBX5 DNA-binding domain alter thermal stability and DNA-binding affinity
Missense mutations can alter the biochemical properties of proteins, including stability, structure, and function, potentially contributing to the development of multiple human diseases. Mutations in TBX5, a transcription factor necessary for heart development, are among the causes of congenital heart diseases. However, further research on biophysical and biochemical mechanisms is needed to understand how missense mutations in transcription factors alter their function in regulating gene expression. In this work, we applied in vitro and in silico approaches to understand how 5 missense mutations in the TBX5 T-box DNA-binding domain (I54T, M74V, I101F, R113K, and R237W) impact protein structure, thermal stability, and DNA-binding affinity to known TBX5 cognate binding sites. Differential scanning fluorimetry showed that mutants I54T and M74V had decreased thermal stability, mutants I101F and R113K had increased stability, and R237W had no significant effect on stability. Additionally, DNA-binding affinity decreased for all 5 missense mutants when evaluated in vitro for known TBX5 genomic binding sites within regulatory elements of Nppa and Camta1 genes. Structural modeling of the TBX5 predicted altered protein conformations and stability due to the loss or gain of amino acid residue interactions. Together, our findings provide biophysical and biochemical mechanisms that can be further explored to establish causality between TBX5 missense mutations and the development of congenital heart diseases.
- 2 August 2025
- Published by Oxford University Press (OUP) in G3: Genes, Genomes, Genetics
- Vol. 15 (10)
Open AccessCongenital heart disease missense mutations in the TBX5 DNA-binding domain alter thermal stability and DNA-binding affinity
Missense mutations can alter the biochemical properties of proteins, including stability, structure, and function, potentially contributing to the development of multiple human diseases. Mutations in TBX5, a transcription factor necessary for heart development, are among the causes of congenital heart diseases. However, further research on biophysical and biochemical mechanisms is needed to understand how missense mutations in transcription factors alter their function in regulating gene expression. In this work, we applied in vitro and in silico approaches to understand how 5 missense mutations in the TBX5 T-box DNA-binding domain (I54T, M74V, I101F, R113K, and R237W) impact protein structure, thermal stability, and DNA-binding affinity to known TBX5 cognate binding sites. Differential scanning fluorimetry showed that mutants I54T and M74V had decreased thermal stability, mutants I101F and R113K had increased stability, and R237W had no significant effect on stability. Additionally, DNA-binding affinity decreased for all 5 missense mutants when evaluated in vitro for known TBX5 genomic binding sites within regulatory elements of Nppa and Camta1 genes. Structural modeling of the TBX5 predicted altered protein conformations and stability due to the loss or gain of amino acid residue interactions. Together, our findings provide biophysical and biochemical mechanisms that can be further explored to establish causality between TBX5 missense mutations and the development of congenital heart diseases.
- Open Access
- 4 June 2025
- Published by Elsevier in STAR Protocols
- Vol. 6 (2) , 103874
Protocol for evaluating the impact of non-coding variants on transcription factor binding and gene expression
- 4 June 2025
- Published by Elsevier in STAR Protocols
- Vol. 6 (2) , 103874
Open AccessProtocol for evaluating the impact of non-coding variants on transcription factor binding and gene expression
- Open Access
Congenital heart disease missense mutations in the TBX5 DNA-binding domain alter thermal stability and DNA-binding affinity
Missense mutations can alter the biochemical properties of proteins, including stability, structure, and function, potentially contributing to the development of multiple human diseases. Mutations in TBX5 , a transcription factor (TF) necessary for heart development, are among the causes of congenital heart diseases (CHD). However, further research on biophysical and biochemical mechanisms is needed to understand how missense mutations in TFs alter their function in regulating gene expression. In this work, we applied in vitro and in silico approaches to understand how five missense mutations in the TBX5 T-box DNA-binding domain (I54T, M74V, I101F, R113K, and R237W) impact protein structure, thermal stability, and DNA-binding affinity to known TBX5 cognate binding sites. Differential Scanning Fluorimetry showed that mutants I54T and M74V decreased thermal stability, whereas I101F and R113K had increased stability. Additionally, DNA-binding affinity decreased for all five missense mutants when evaluated in vitro for known TBX5 genomic binding sites within regulatory elements of Nppa and Camta1 genes . Structural modeling of the TBX5 T-box domain predicted altered protein conformation and stability due to the loss or gain of amino acid residue interactions. Together, our findings provide biophysical and biochemical mechanisms that can be further explored to establish causality between TBX5 missense mutations and the development of CHDs. Article Summary: Mutations in genes crucial for heart development, such as TBX5 , a cardiac transcription factor (TF), have been shown to cause congenital heart diseases. However, the functional consequences of missense mutations in cardiac TF have not been fully explored. In this work, we performed biochemical evaluations and found significant changes in thermal stability and DNA-binding of five TBX5 missense mutants (I54T, M74V, I101F, R113K, and R237W). Additionally, we generated in silico predictions of protein structure, stability, and pathogenicity for the five missense mutants. Our approach is scalable to other TF mutants crucial for organ development to further our understanding of congenital disease etiology. Graphical
Open AccessCongenital heart disease missense mutations in the TBX5 DNA-binding domain alter thermal stability and DNA-binding affinity
Missense mutations can alter the biochemical properties of proteins, including stability, structure, and function, potentially contributing to the development of multiple human diseases. Mutations in TBX5 , a transcription factor (TF) necessary for heart development, are among the causes of congenital heart diseases (CHD). However, further research on biophysical and biochemical mechanisms is needed to understand how missense mutations in TFs alter their function in regulating gene expression. In this work, we applied in vitro and in silico approaches to understand how five missense mutations in the TBX5 T-box DNA-binding domain (I54T, M74V, I101F, R113K, and R237W) impact protein structure, thermal stability, and DNA-binding affinity to known TBX5 cognate binding sites. Differential Scanning Fluorimetry showed that mutants I54T and M74V decreased thermal stability, whereas I101F and R113K had increased stability. Additionally, DNA-binding affinity decreased for all five missense mutants when evaluated in vitro for known TBX5 genomic binding sites within regulatory elements of Nppa and Camta1 genes . Structural modeling of the TBX5 T-box domain predicted altered protein conformation and stability due to the loss or gain of amino acid residue interactions. Together, our findings provide biophysical and biochemical mechanisms that can be further explored to establish causality between TBX5 missense mutations and the development of CHDs. Article Summary: Mutations in genes crucial for heart development, such as TBX5 , a cardiac transcription factor (TF), have been shown to cause congenital heart diseases. However, the functional consequences of missense mutations in cardiac TF have not been fully explored. In this work, we performed biochemical evaluations and found significant changes in thermal stability and DNA-binding of five TBX5 missense mutants (I54T, M74V, I101F, R113K, and R237W). Additionally, we generated in silico predictions of protein structure, stability, and pathogenicity for the five missense mutants. Our approach is scalable to other TF mutants crucial for organ development to further our understanding of congenital disease etiology. Graphical
- Open Access
- 12 February 2025
- Published by Elsevier in Human Genetics and Genomics Advances
- Vol. 6 (2) , 100415
Cardiovascular disease-associated non-coding variants disrupt GATA4-DNA binding and regulatory functions
- 12 February 2025
- Published by Elsevier in Human Genetics and Genomics Advances
- Vol. 6 (2) , 100415
Open AccessCardiovascular disease-associated non-coding variants disrupt GATA4-DNA binding and regulatory functions
- Open Access
Cardiovascular Disease-Associated Non-Coding Variants Disrupt GATA4-DNA Binding and Regulatory Functions
Genome-wide association studies have mapped over 90% of cardiovascular disease (CVD)-associated variants within the non-coding genome. Non-coding variants in regulatory regions of the genome, such as promoters, enhancers, silencers, and insulators, can alter the function of tissue-specific transcription factors (TFs) proteins and their gene regulatory function. In this work, we used a computational approach to identify and test CVD-associated single nucleotide polymorphisms (SNPs) that alter the DNA binding of the human cardiac transcription factor GATA4. Using a gapped k-mer support vector machine (GKM-SVM) model, we scored CVD-associated SNPs localized in gene regulatory elements in expression quantitative trait loci (eQTL) detected in cardiac tissue to identify variants altering GATA4-DNA binding. We prioritized four variants that resulted in a total loss of GATA4 binding (rs1506537 and rs56992000) or the creation of new GATA4 binding sites (rs2941506 and rs2301249). The identified variants also resulted in significant changes in transcriptional activity proportional to the altered DNA-binding affinities. In summary, we present a comprehensive analysis comprised of in silico, in vitro, and cellular evaluation of CVD-associated SNPs predicted to alter GATA4 function. Graphical Highlights: An integrative computational approach combining functional genomics data and machine learning was implemented to prioritize potential causal genetic variants associated with cardiovascular disease (CVD). We prioritized and validated CVD-associated SNPs that created or destroyed genomic binding sites of the cardiac transcription factor GATA4. Changes in GATA4-DNA binding resulted in significant changes in GATA4-dependent transcriptional activity in human cells. Our results contribute to the mechanistic understanding of cardiovascular disease-associated non-coding variants impacting GATA4 function.
Open AccessCardiovascular Disease-Associated Non-Coding Variants Disrupt GATA4-DNA Binding and Regulatory Functions
Genome-wide association studies have mapped over 90% of cardiovascular disease (CVD)-associated variants within the non-coding genome. Non-coding variants in regulatory regions of the genome, such as promoters, enhancers, silencers, and insulators, can alter the function of tissue-specific transcription factors (TFs) proteins and their gene regulatory function. In this work, we used a computational approach to identify and test CVD-associated single nucleotide polymorphisms (SNPs) that alter the DNA binding of the human cardiac transcription factor GATA4. Using a gapped k-mer support vector machine (GKM-SVM) model, we scored CVD-associated SNPs localized in gene regulatory elements in expression quantitative trait loci (eQTL) detected in cardiac tissue to identify variants altering GATA4-DNA binding. We prioritized four variants that resulted in a total loss of GATA4 binding (rs1506537 and rs56992000) or the creation of new GATA4 binding sites (rs2941506 and rs2301249). The identified variants also resulted in significant changes in transcriptional activity proportional to the altered DNA-binding affinities. In summary, we present a comprehensive analysis comprised of in silico, in vitro, and cellular evaluation of CVD-associated SNPs predicted to alter GATA4 function. Graphical Highlights: An integrative computational approach combining functional genomics data and machine learning was implemented to prioritize potential causal genetic variants associated with cardiovascular disease (CVD). We prioritized and validated CVD-associated SNPs that created or destroyed genomic binding sites of the cardiac transcription factor GATA4. Changes in GATA4-DNA binding resulted in significant changes in GATA4-dependent transcriptional activity in human cells. Our results contribute to the mechanistic understanding of cardiovascular disease-associated non-coding variants impacting GATA4 function.
- Open Access
- 25 April 2024
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (20) , 13787-13800
Selection, characterization, and biosensing applications of DNA aptamers targeting cyanotoxin BMAA
Scientists have established a connection between environmental exposure to toxins like β-N-methylamino-l-alanine (BMAA) and a heightened risk of neurodegenerative disorders.
- 25 April 2024
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (20) , 13787-13800
Open AccessSelection, characterization, and biosensing applications of DNA aptamers targeting cyanotoxin BMAA
Scientists have established a connection between environmental exposure to toxins like β-N-methylamino-l-alanine (BMAA) and a heightened risk of neurodegenerative disorders.
- Open Access
- 1 March 2024
- Published by IMR Press in Frontiers in Bioscience-Scholar
- Vol. 16 (1) , 4
Decoding Non-coding Variants: Recent Approaches to Studying Their Role in Gene Regulation and Human Diseases
Genome-wide association studies (GWAS) have mapped over 90% of disease- and quantitative-trait-associated variants within the non-coding genome. Non-coding regulatory DNA (e.g., promoters and enhancers) and RNA (e.g., 5′ and 3′ UTRs and splice sites) are essential in regulating temporal and tissue-specific gene expressions. Non-coding variants can potentially impact the phenotype of an organism by altering the molecular recognition of the cis-regulatory elements, leading to gene dysregulation. However, determining causality between non-coding variants, gene regulation, and human disease has remained challenging. Experimental and computational methods have been developed to understand the molecular mechanism involved in non-coding variant interference at the transcriptional and post-transcriptional levels. This review discusses recent approaches to evaluating disease-associated single-nucleotide variants (SNVs) and determines their impact on transcription factor (TF) binding, gene expression, chromatin conformation, post-transcriptional regulation, and translation.
- 1 March 2024
- Published by IMR Press in Frontiers in Bioscience-Scholar
- Vol. 16 (1) , 4
Open AccessDecoding Non-coding Variants: Recent Approaches to Studying Their Role in Gene Regulation and Human Diseases
Genome-wide association studies (GWAS) have mapped over 90% of disease- and quantitative-trait-associated variants within the non-coding genome. Non-coding regulatory DNA (e.g., promoters and enhancers) and RNA (e.g., 5′ and 3′ UTRs and splice sites) are essential in regulating temporal and tissue-specific gene expressions. Non-coding variants can potentially impact the phenotype of an organism by altering the molecular recognition of the cis-regulatory elements, leading to gene dysregulation. However, determining causality between non-coding variants, gene regulation, and human disease has remained challenging. Experimental and computational methods have been developed to understand the molecular mechanism involved in non-coding variant interference at the transcriptional and post-transcriptional levels. This review discusses recent approaches to evaluating disease-associated single-nucleotide variants (SNVs) and determines their impact on transcription factor (TF) binding, gene expression, chromatin conformation, post-transcriptional regulation, and translation.
- Open Access
- 3 November 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (12) , 105423
Prioritizing cardiovascular disease-associated variants altering NKX2-5 and TBX5 binding through an integrative computational approach
- 3 November 2023
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 299 (12) , 105423
Open AccessPrioritizing cardiovascular disease-associated variants altering NKX2-5 and TBX5 binding through an integrative computational approach